Growth of aberrant brain cells is known as a brain tumour. The brain's architecture is extremely intricate, with several regions controlling various nervous system processes. The brain's protective coating, the underbelly, the brainstem, the sinuses, the nasal cavity, and many other parts of the skull are all potential sites for brain tumour development. Because they can press against healthy brain tissue or spread there, brain tumours pose a threat to the general public. Additionally, some brain tumours have the potential to develop into cancer. They may be problematic if they obstruct the movement of the fluid that surrounds the brain since this may result in an increase in the pressure within the skull. Certain malignancies have the potential to spread from one part of the brain or spine to another via the spinal fluid.

Although all brain tumours are tumours, not all brain tumours are cancerous. Benign brain tumours are those that are not malignant. The majority of benign brain tumours are slow-growing, have clear boundaries, and seldom metastasize. Even benign tumours can pose a threat. They can hurt and squeeze the brain, seriously disrupting it. A benign brain tumour that is in a critical part of the brain can be fatal. A benign tumour may very infrequently develop into a malignant one. Meningioma, vestibular schwannoma, and pituitary adenoma are a few examples of tumours that are often benign. Brain tumours that are malignant are cancerous. Typically, they spread quickly and attack nearby healthy brain tissue. Due to the changes it makes to the essential brain structures, brain cancer can be fatal. Tumours that originate in the brain are called primary brain tumours. Meningioma and glioma are two examples of cancers that typically start in the brain. There is a very small chance that these tumours will separate and spread to the spinal cord and other areas of the brain. Tumours typically spread from other body areas to the brain.

Secondary brain tumours, also known as metastatic brain tumours, are cancerous tumours that start out in another part of the body and move to the brain. About four times as many people develop metastatic brain tumours as original brain tumours. They may spread quickly and encroach on surrounding brain tissue. The symptoms of a brain tumour will vary depending on where the tumour is located because different areas of the brain are responsible for different tasks. For instance, a brain tumour in the cerebellum in the rear of the head may make it difficult to move, walk, balance, and coordinate one's movements. Changes in vision may occur if the tumour impacts the optic pathway, which is responsible for seeing. The following are typically the most typical signs of a brain tumour: Headaches, convulsions or seizures, finding it difficult to think, speak, or write, changes in behaviour or personality weakness, numbness, or paralysis in a single body portion or side.

balance issues, faintness, or unsteadiness, decline in hearing, vision morphs, confusion and fuzziness, No memory Surgery is the most often used treatment for brain tumours. Some cancers may just require surgical removal, followed by ongoing surveillance. The excision of brain tumours frequently involves craniotomies, neuro-endoscopies, laser ablation, and laser interstitial thermal treatment. In order to decrease the tumour, limit its growth, and/or stop it from returning, radiation therapy and chemotherapy are both effective treatments for brain cancer. Proton therapy, stereotactic radiosurgery, and external beam radiation therapy are a few of the radiation therapies for brain tumours.

Cancer Clinical Research peer reviewed, open access periodical dedicated to publish the clinical advancements in the cancer research and therapy providing end-to-end solutions, from diagnosis thorough various stages of cancer therapy, pharmaceutical advancements, drug delivery, clinical trials, rehabilitation and care.

Authors can submit their manuscripts as an email attachment to ccr@alliedacademiesscholars.com.

Best Wishes,
Journal Co-ordinator
Journal of Cancer Clinical Research